Back to Results

ConvaTec Group plc ADR (CNVVY)

ConvaTec Group plc ADR is a depositary receipt representing the common stock of ConvaTec Group plc and is traded on OTC Markets. The underlying company develops, manufactures, and sells medical products, services, and technologies used in the management of chronic conditions across Europe, North America, and other international markets. Its portfolio includes advanced wound care products for acute and chronic wounds, ostomy care solutions for people living with a stoma, continence care products and related services, and infusion care solutions such as disposable infusion sets used with diabetes insulin pumps and certain continuous infusion treatments. The company sells through pharmacies, hospitals, and other acute and post-acute healthcare providers, working both directly and through distributors and wholesalers. Founded in 1978, Convatec is headquartered in London, United Kingdom.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-CNVV.Y
$13.51
17.0% Upside
Fair
$13.80
19.5% Upside
Undervalued
Great
—
—
0.23
2.9%
August 4, 2026
32.9x
3.8x
2.4x
5.722 B
7.21 B
20.9%
99.8%
5.2
80.0%
191.4%
Send a message
Valuation • Fair Value

ConvaTec Group plc ADR (OTC-CNVV.Y) Fair Value by Valuation Model

Compare the primary fair value estimate for ConvaTec Group plc ADR (OTC-CNVV.Y) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$13.51

Estimated upside of 17.0% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$14.83

Discounted cash flow valuation reference.

Ben Graham Formula Value

$4.01

Classic Ben Graham valuation formula reference.

DDM Fair Value

$15.44

Dividend discount model valuation reference.

EPV Fair Value

$6.14

Earnings power value estimate.

Comps Fair Value

$12.79

Comparable-company valuation reference.

Analyst Price Target

$13.80

Analysts imply upside of 19.5%.

How to read these valuation models

Use this section to compare the primary fair value estimate for ConvaTec Group plc ADR (OTC-CNVV.Y) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for ConvaTec Group plc ADR (OTC-CNVV.Y)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

2.439 B

Current operating scale indicator.

Revenue Forecast

2.568 B

Forward revenue estimate.

EBITDA

587 M

Current operating profitability reference.

EBITDA Forecast

684.7 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review ConvaTec Group plc ADR (OTC-CNVV.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for ConvaTec Group plc ADR (OTC-CNVV.Y)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.71

No elevated caution signal from this screen.

Altman Z-Score

5.2

Relatively strong balance-sheet zone.

FCF / Net Income

191.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for ConvaTec Group plc ADR (OTC-CNVV.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for ConvaTec Group plc ADR (OTC-CNVV.Y)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 4, 2026

Days to Earnings

14

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.9%

Income yield reference.

Upcoming Dividend

0.23

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

80.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for ConvaTec Group plc ADR (OTC-CNVV.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

ConvaTec Group plc ADR (OTC-CNVV.Y) Stock Forecast & Technical Outlook

Review ConvaTec Group plc ADR (OTC-CNVV.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for ConvaTec Group plc ADR (OTC-CNVV.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for ConvaTec Group plc ADR (OTC-CNVV.Y) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for ConvaTec Group plc ADR (OTC-CNVV.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for ConvaTec Group plc ADR (OTC-CNVV.Y) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for ConvaTec Group plc ADR (OTC-CNVV.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for ConvaTec Group plc ADR (OTC-CNVV.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for ConvaTec Group plc ADR (OTC-CNVV.Y) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

ConvaTec Group plc ADR (OTC-CNVV.Y) Stock FAQ

Quick answers about ConvaTec Group plc ADR (OTC-CNVV.Y) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$13.51
Estimated upside 17.0%
Valuation Rating
Undervalued
Estimated upside of 17.0%
Analyst Target
$13.80
Implied upside 19.5%
Financial Health
Great
Current financial-health read

The current fair value estimate for ConvaTec Group plc ADR (OTC-CNVV.Y) is $13.51. This implies an estimated upside of 17.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 17.0% versus the current market price.

The available analyst price target for ConvaTec Group plc ADR (OTC-CNVV.Y) is $13.80. The analyst target implies estimated upside of 19.5%.

The current financial health read for ConvaTec Group plc ADR (OTC-CNVV.Y) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for ConvaTec Group plc ADR (OTC-CNVV.Y) is August 4, 2026.

Based on the current data, dividend yield is 2.9%, upcoming dividend amount is 0.23.

The current P/E ratio listed for ConvaTec Group plc ADR (OTC-CNVV.Y) is 32.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for ConvaTec Group plc ADR is 5.722 B.

The current enterprise value listed for ConvaTec Group plc ADR is 7.21 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for ConvaTec Group plc ADR is OTC-CNVV.Y, and the stock is listed on OTC Markets.

ConvaTec Group plc ADR (OTC-CNVV.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for ConvaTec Group plc ADR is 20.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for ConvaTec Group plc ADR is 99.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks on OTC Markets View more

Essilor International SA (ESLOY) Essilor International SA (ESLOY)
Hoya Corp (HOCPY) Hoya Corp (HOCPY)
Siemens Healthineers AG ADR (SMMNY) Siemens Healthineers AG ADR (SMMNY)
Resmed Inc DRC (RSMDF) Resmed Inc DRC (RSMDF)
Terumo Corp ADR (TRUMY) Terumo Corp ADR (TRUMY)
Straumann Holding AG ADR (SAUHY) Straumann Holding AG ADR (SAUHY)
Sonova Holding AG (SONVY) Sonova Holding AG (SONVY)
Coloplast A (CLPBY) Coloplast A (CLPBY)
Fisher & Paykel Healthcare Ltd (FSPKF) Fisher & Paykel Healthcare Ltd (FSPKF)
Olympus Corp (OLYMY) Olympus Corp (OLYMY)
Demant A/S ADR (WILYY) Demant A/S ADR (WILYY)
Getinge Industrier AB (GNGBY) Getinge Industrier AB (GNGBY)
Sysmex Corp (SSMXY) Sysmex Corp (SSMXY)
CochLear Ltd ADR (CHEOY) CochLear Ltd ADR (CHEOY)
Ansell Ltd ADR (ANSLY) Ansell Ltd ADR (ANSLY)
Carl Zeiss Meditec AG ADR (CZMWY) Carl Zeiss Meditec AG ADR (CZMWY)
Shandong Weigao Group Medical Polymer Co Ltd ADR (SHWGY) Shandong Weigao Group Medical Polymer Co Ltd ADR (SHWGY)
Elekta AB ADR (EKTAY) Elekta AB ADR (EKTAY)
Nihon Kohden Corp ADR (NHNKY) Nihon Kohden Corp ADR (NHNKY)
Top Glove Corporation Bhd ADR (TGLVY) Top Glove Corporation Bhd ADR (TGLVY)
Cyberdyne Inc ADR (CYBQY) Cyberdyne Inc ADR (CYBQY)
Paxman AB (PXMBF) Paxman AB (PXMBF)
Zomedica Corp (ZOMDF) Zomedica Corp (ZOMDF)
Positron Corp (POSC) Positron Corp (POSC)